Produkty 330800-94-7

CAS 330800-94-7 występuje w naszej ofercie pod nazwami: 13(R)-HODE cholesteryl ester, 13(R)–HODE cholesteryl ester. Oferty producentów: TargetMol, GLPBio, MedChemExpress. Dostępne opakowania: 25ug, 50ug, 100ug, 100μg, 25μg, 50μg, Get quote.

13(R)-HODE cholesteryl ester
TargetMol, MedChemExpress
  • opakowanie: 25ug, 50ug, 100ug, Get quote
  • Warianty: 4
od 3619,96
Zobacz produkt
13(R)–HODE cholesteryl ester
GLPBio
  • opakowanie: 100μg, 25μg, 50μg
  • Warianty: 3
od 1837,37
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9E,11E,13R)-13-hydroxyoctadeca-9,11-dienoate (CAS 330800-94-7) to związek chemiczny o wzorze sumarycznym C45H76O3 i masie molowej 665.1 g/mol. Nazwa systematyczna IUPAC: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9E,11E,13R)-13-hydroxyoctadeca-9,11-dienoate. InChIKey: RZXYPSUQZUUHPD-SDZZETQDSA-N.

Dane identyfikacyjne
Wzór sumarycznyC45H76O3
Masa molowa665.1 g/mol
Nazwa IUPAC[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9E,11E,13R)-13-hydroxyoctadeca-9,11-dienoate
InChIKeyRZXYPSUQZUUHPD-SDZZETQDSA-N
SMILESCCCCC[C@H](/C=C/C=C/CCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 13(R)-HODE cholesteryl ester, 13R-hydroxy-9Z,11E-octadecadienoic acid, cholesteryl ester
Powiązane formy tego związku
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoate C45H76O3
Izomery (ten sam wzór sumaryczny)
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9R,10E,12Z)-9-hydroxyoctadeca-10,12-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9S,10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9R,10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate C45H76O3